Vipshop Holdings Ltd - ADR vs Zoetis Inc — how do they compare? Vipshop Holdings Ltd - ADR trades at $12.96 (market cap $6.05B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 5× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.87%). Which is the better fit depends on your goals — on Pluang, investors hold Vipshop Holdings Ltd - ADR for 49 Days and Zoetis Inc for 70 Days on average.
| VIPS | ZTS | |
|---|---|---|
Market Cap | $6.05B | $30.20B |
Volume | 3,719,230 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $20.29 | $147.53 |
52-Week Low | $12.09 | $69.09 |
Typical Hold Time | 49 Days | 70 Days |
Enterprise Value | $2.87B | $37.76B |
Dividend Yield | 4.87% | 2.9% |
Signals from Pluang's Aura AI — not financial advice
Vipshop Holdings trades at $12.90, up 1.02% with mixed technical signals showing neutral overall momentum. The stock presents compelling valuation metrics with P/E of 4.1 and P/S of 0.4, though recent quarterly earnings showed two misses. Revenue has declined from $112.9B in 2023 to $105.9B in 2025, while net income margin improved to 9.82%. Analyst consensus remains bullish with 53.57% buy ratings and $16.17 price target, representing 25% upside potential.
The investment case balances deep value against growth challenges. While valuation multiples appear attractive and cash flow generation remains solid, revenue stagnation and consumer spending headwinds present near-term risks. The stock offers potential for re-rating if management can stabilize top-line performance while maintaining current profitability levels.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →